Andy Deig

Andy Deig is Vice President of Financial Planning and Analysis and Chief of Staff to the CEO at Immunovant. Prior to joining Immunovant, Andy spent almost 13 years at Eli Lilly & Company where he held numerous roles in different functions across the business, including finance, sales, and value & access. Most recently, Andy served as the national account manager for McKesson and Walmart after leading the commercial integration of Dermira.

Andy earned a B.A. from Wabash College in 2008 with majors in Economics and German and an M.B.A. in health sector management and strategy from Duke’s Fuqua School of Business in 2016.